REFERENCE : AUTISM MANAGEMENT

·         Scahill L, Aman MG, McDougle CJ, et al. A prospective open trial of guanfacine in children with pervasive developmental disorders. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. J Child Adolesc Psychopharmacol. 2006;16 :589 –598[CrossRef][ISI][Medline]

·         Posey DJ, Puntney JI, Sasher TM, Kem DL, McDougle CJ. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol. 2004;14 :233 –241[CrossRef][ISI][Medline]

·         Jou RJ, Handen BL, Hardan AY. Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2005;15 :325 –330[CrossRef][ISI][Medline]

·         Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJ. Open-label atomoxetine for attention-deficit/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006;16 :599 –610[CrossRef][ISI][Medline]

·         Arnold LE, Aman MG, Cook AM, et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry. 2006;45 :1196 –1205[CrossRef][ISI][Medline]

·         Vitiello B. An update on publicly funded multisite trials in pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am. 2006;15 :1 –12[CrossRef][ISI][Medline]

·         Buchsbaum MS, Hollander E, Haznedar MM, et al. Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. Int J Neuropsychopharmacol. 2001;4 :119 –125[CrossRef][ISI][Medline]

·         Namerow LB, Thomas P, Bostic JQ, Prince J, Monuteaux MC. Use of citalopram in pervasive developmental disorders. J Dev Behav Pediatr. 2003;24 :104 –108[ISI][Medline]

·         Owley T, Walton L, Salt J, et al. An open-label trial of escitalopram in pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry. 2005;44 :343 –348[CrossRef][ISI][Medline]

·         Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol. 2006;9 :209 –213[CrossRef][ISI][Medline]

·         Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry. 2001;62 :530 –534[ISI][Medline]

·         Rugino TA, Samsock TC. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr. 2002;23 :225 –230[Medline]

·         Hardan AY, Jou RJ, Handen BL. A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2004;14 :426 –432[CrossRef][ISI][Medline]

·         Connor DF, Ozbayrak KR, Benjamin S, Ma Y, Fletcher KE. A pilot study of nadolol for overt aggression in developmentally delayed individuals. J Am Acad Child Adolesc Psychiatry. 1997;36 :826 –834[CrossRef][ISI][Medline]

·         Ratey JJ, Mikkelsen E, Sorgi P, et al. Autism: the treatment of aggressive behaviors. J Clin Psychopharmacol. 1987;7 :35 –41[ISI][Medline]

·         Reed MD, Findling RL. Overview of current management of sleep disturbances in children: I—pharmacotherapy. Curr Ther Res. 2002;63(suppl B) :B18 –B37[CrossRef]

·         Mehta UC, Patel I, Castello FV. EEG sedation for children with autism. J Dev Behav Pediatr. 2004;25 :102 –104[CrossRef][ISI][Medline]

·         Ingrassia A, Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders: a case series. Eur Child Adolesc Psychiatry. 2005;14 :34 –40[CrossRef][ISI][Medline]

·         Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2001;11 :267 –277[CrossRef][ISI][Medline]

·         Buitelaar JK, van der Gaag RJ, van der Hoeven J. Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 1998;59 :56 –59[ISI][Medline]

·         Kowatch RA, DelBello MD. Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc Psychiatr Clin N Am. 2006;15 :73 –108[CrossRef][ISI][Medline]

·         Cheng-Shannon J, McGough JJ, Pataki C, McCracken JT. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2004;14 :372 –394[CrossRef][ISI][Medline]

·         DeLong R. Children with autistic spectrum disorder and a family history of affective disorder. Dev Med Child Neurol. 1994;36 :674 –687[ISI][Medline]

·         Kerbeshian J, Burd L, Fisher W. Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. J Clin Psychopharmacol. 1987;7 :401 –405[ISI][Medline]

·         Steingard R, Biederman J. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry. 1987;26 :932 –935[ISI][Medline]

·         Aman MG, Novotny S, Samango-Sprouse C, et al. Outcome measures for clinical drug trials in autism. CNS Spectr. 2004;9 :36 –47[ISI][Medline]

·         National Center for Complementary and Alternative Medicine. Expanding horizons of healthcare: five year strategic plan 2001–2005. Washington, DC: US Department of Health and Human Services; 2000

·         Zollman C, Vickers A. What is complementary medicine? BMJ. 1999;319 :693 –696[Free Full Text]

·         Challman TD, Voigt RG, Myers SM. Nonstandard therapies in developmental disabilities. In: Accardo PJ, ed. Capute & Accardo’s Neurodevelopmental Disabilities in Infancy and Childhood: Vol I. Neurodevelopmental Diagnosis and Treatment. 3rd ed. Baltimore, MD: Paul H. Brookes; 2008:721 –743

·         Gupta VB. Complementary and alternative treatments for autism. In: Gupta VB, ed. Autistic Spectrum Disorders in Children (Pediatric Habilitation Series Volume 12). New York, NY: Marcel Dekker; 2004:239 –254

·         Levy SE, Hyman SL. Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev. 2005;11 :131 –142[CrossRef][ISI][Medline]

·         Harrington JW, Rosen L, Garnecho A, Patrick PA. Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. J Dev Behav Pediatr. 2006;27 :S156 –S161[CrossRef][ISI][Medline]

·         Levy SE, Mandell DS, Merhar S, Ittenbach RF, Pinto-Martin JA. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. J Dev Behav Pediatr. 2003;24 :418 –423[CrossRef][ISI][Medline]

·         Wong HHL, Smith RG. Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. J Autism Dev Disord. 2006;36 :901 –909[CrossRef][ISI][Medline]

·         Sibinga EM, Ottolini MC, Duggan AK, Wilson MH. Parent-pediatrician communication about complementary and alternative medicine use for children. Clin Pediatr (Phila). 2004;43 :367 –373[Abstract/Free Full Text]

 

 

Supported by

CLINIC FOR CHILDREN

YUDHASMARA FOUNDATION

Office : JL TAMAN BENDUNGAN ASAHAN 5 JAKARTA PUSAT, JAKARTA INDONESIA 10210

Phone : (021) 70081995 – 5703646

Email : judarwanto@gmail.com

www.childrenclinic.wordpress.com/

 

 

Clinical and Editor in Chief :

Dr WIDODO JUDARWANTO

Address : JL TAMAN BENDUNGAN ASAHAN 5 JAKARTA PUSAT, JAKARTA INDONESIA 10210

phone : 62(021) 70081995 – 62(021) 5703646, mobile : 0817171764

email : judarwanto@gmail.com

 

 

 

 

Copyright © 2009, Clinic For children Information Education Network. All rights reserved.

 

 

 

Tinggalkan Balasan

Isikan data di bawah atau klik salah satu ikon untuk log in:

Logo WordPress.com

You are commenting using your WordPress.com account. Logout / Ubah )

Gambar Twitter

You are commenting using your Twitter account. Logout / Ubah )

Foto Facebook

You are commenting using your Facebook account. Logout / Ubah )

Foto Google+

You are commenting using your Google+ account. Logout / Ubah )

Connecting to %s